The call from the nursing home came just before dawn, jolting Martha Sherwood awake.
A new drug developed at Lancaster University in the UK that may help to prevent the early stages of Alzheimer's disease is to enter clinical trials.
Scientists may have just gone and done the unthinkable by identifying an anti-aging drug.
The lower five-star ratings for nursing homes that were forecast in February by the federal government are evidenced in a new analysis by the Kaiser Family Foundation. That analysis found that more than one-third of the nation’s 15,500 nursing homes, caring for 39 percent of all nursing home residents, received one- or two-star ratings under the Centers for Medicare & Medicaid Services’ (CMS’) recently revamped five-star quality rating system.
Large cohort study finds mortality rate negatively associated with level of physical activity.
The first comprehensive study into injury related or premature deaths of residents in nursing homes has found that more than 80 per cent are from falls.
Health care partnerships may be the wave of the future, but for senior living providers and Accountable Care Organizations (ACOs), something’s got to give.
A new study suggests that medical marijuana pills may not help treat behavioral symptoms of dementia, such as aggression, pacing and wandering. The research is published online issue of Neurology, the medical journal of the American Academy of Neurology. However, researchers did find that the drug dosage used in the clinical trial was safe and well-tolerated.